Emina Halilbasic

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Primary sclerosing cholangitis: Time to rethink imaging criteria for early disease detection.

Primary sclerosing cholangitis: Time to rethink imaging criteria for early disease detection.

Journal: Journal of hepatology

Published: January 23, 2026

Characterisation and Prognostic Implication of Cholestasis After Burn Injury.

Characterisation and Prognostic Implication of Cholestasis After Burn Injury.

Journal: Alimentary pharmacology & therapeutics

Published: July 22, 2025

Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis.

Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis.

Journal: Alimentary pharmacology & therapeutics

Published: February 10, 2025

Can a comprehensive gadoxetic acid-enhanced MRI with MRCP be used for early diagnosis, monitoring, and outcome prediction of PSC?

Can a comprehensive gadoxetic acid-enhanced MRI with MRCP be used for early diagnosis, monitoring, and outcome prediction of PSC?

Journal: European radiology

Published: August 18, 2024

Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong Track.

Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong Track.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 14, 2024

24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting TH17 pathogenicity and transdifferentiation.

24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting TH17 pathogenicity and transdifferentiation.

Journal: Gut

Published: July 09, 2024

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: May 28, 2024

Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome.

Presence of cholestasis and its impact on survival in SARS-CoV-2 associated acute respiratory distress syndrome.

Journal: Scientific reports

Published: April 16, 2024

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 09, 2024

Primary sclerosing cholangitis-Diagnosis and treatment 2024

Primary sclerosing cholangitis-Diagnosis and treatment 2024

Journal: Innere Medizin (Heidelberg, Germany)

Published: March 05, 2024

Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture.

Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture.

Journal: European radiology

Published: January 11, 2024

Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.

Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.

Journal: Alimentary pharmacology & therapeutics

Published: November 12, 2023

Showing 1-12 of 67

Last Updated: 09/26/2026